资讯

Mashable SEA55 分钟
Now we know who's getting 23andMe's DNA data. Meet Regeneron Pharmaceuticals.
On Monday, Regeneron Pharmaceuticals announced that it would acquire most of 23andMe's assets for $256 million. According to ...